Logo.png
Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out - MediciNova, Mesoblast, Veru, Pluristem, Avalo, Boehringer Ingelheim, Genentech, Windtree
13 sept. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Market to Observe Stunning Growth by 2032, Assesses DelveInsight | Leading Companies to Watch Out - MediciNova,...
Logo.png
Acute Respiratory Distress Syndrome Pipeline Drugs and Companies Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
22 déc. 2021 20h00 HE | DelveInsight Business Research LLP
Los Angeles, USA, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Pipeline Drugs and Companies Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of...
logo.png
Arch Biopartners Receives Ethics Committee Approval in Turkey to Dose Additional Patients in the Phase II Trial for LSALT Peptide
02 févr. 2021 07h56 HE | Arch Biopartners
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the İstanbul...